Fulgent Genetics (MEX:FLGT) Additional Paid-In Capital : MXN8,486 Mil(As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Fulgent Genetics Additional Paid-In Capital?

Fulgent Genetics's quarterly additional paid-in capital declined from Sep. 2023 (MXN8,958 Mil) to Dec. 2023 (MXN8,516 Mil) but then stayed the same from Dec. 2023 (MXN8,516 Mil) to Mar. 2024 (MXN8,486 Mil).

Fulgent Genetics's annual additional paid-in capital declined from Dec. 2021 (MXN10,296 Mil) to Dec. 2022 (MXN9,486 Mil) and declined from Dec. 2022 (MXN9,486 Mil) to Dec. 2023 (MXN8,516 Mil).

Fulgent Genetics Additional Paid-In Capital Historical Data

The historical data trend for Fulgent Genetics's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fulgent Genetics Additional Paid-In Capital Chart

Fulgent Genetics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

2,754.65

8,316.15

10,296.14

9,486.46

8,516.29

Fulgent Genetics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Additional Paid-In Capital	Get a 7-Day Free Trial															8,940.06	8,676.10	8,957.88	8,516.29	8,486.15

Fulgent Genetics Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Fulgent Genetics Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Fulgent Genetics's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Fulgent Genetics (MEX:FLGT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Fulgent Genetics Inc (MEX:FLGT) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

FLGT:USA 7F0:Germany

Address

4978 Santa Anita Avenue, Temple City, CA, USA, 91780

Website

https://www.fulgentgenetics.com

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. Genetic testing offers the possibility of early identification of a disease or a genetic predisposition to disease and enhanced disease treatment and prognosis. Fulgent's product portfolio includes Genes & Panels, Known Mutation, Genomic Testing, Hereditary Cancer, Carrier Screening, Tumor Profiling, and Sequencing Service. Its customers are categorized as Insurance; Institutional, which includes hospitals, medical institutions, laboratories, governmental bodies, municipalities, and large corporations; and Patients. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.